N-Phenacylthiazolium bromide explained

N-Phenacylthiazolium bromide (PTB)[1] is a cross-link breaker that in one study has been shown to prevent vascular advanced glycation end-product accumulation in diabetic rats.[2]

Notes and References

  1. N-Phenacylthiazolium bromide inhibits the advanced glycation end product (AGE)-AGE receptor axis to modulate experimental periodontitis in rats. Po-Chun. Chang. Sheng-Chueh. Tsai. Li Yen. Chong. Man-Jung. Kao. July 22, 2014. Journal of Periodontology. 85. 7. e268–276. 10.1902/jop.2014.130554. 24988129.
  2. 10855541 . The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation . Diabetologia . 43 . 5 . 660–664 . 2000 . Cooper. M. E. . Thallas . V . Forbes . J . Scalbert . E . Sastra . S . Darby . I . Soulis . T . 10.1007/s001250051355. free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "N-Phenacylthiazolium bromide".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.